deepull
Pre-clinicalDirect-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens
Founded
2019
Focus
Diagnostics
About
Direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens
Funding History
2Total raised: $12.5M
Series A$10MAsabys PartnersMar 15, 2023
Seed$2.5MAsabys PartnersJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationBarcelona, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile